Angiotensin converting enzyme inhibitor induced hyperkalaemic paralysis.
Secondary hyperkalaemic paralysis is a rare condition often mimicking the Guillain-Barré syndrome. There have been a few case reports of hyperkalaemia caused by renal failure, trauma, and drugs where the presentation has been with muscle weakness. A case of hyperkalaemic paralysis caused by an angiotensin converting enzyme inhibitor is reported.
Dutta
D
D
Department of Medicine, Kidderminster General Hospital, Bewdley Road, Kidderminster DY11 6RJ, UK.
Fischler
M
M
McClung
A
A
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D003937:Diagnosis, Differential; D004562:Electrocardiography; D004573:Electrolytes / Q000097:blood; D004656:Enalapril / Q000009:adverse effects*; D020275:Guillain-Barre Syndrome / Q000175:diagnosis; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D010243:Paralysis / Q000139:chemically induced*; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced
D000806:Angiotensin-Converting Enzyme Inhibitors; D004573:Electrolytes; D004656:Enalapril; D003404:Creatinine